Co-delivery of gefitinib and curcumin via zein-based nanoparticles to enhance EGFR signaling inhibition and prevent cancer progression
Fields of Study & Subjects
Curcumin's Biomedical Applications
Nanoplatforms for cancer theranostics
Nanoparticle-Based Drug Delivery
Publication details
- Journal / source
- Journal of Drug Delivery Science and Technology
- Publisher
- Elsevier BV
- Volume
- 117
- Pages
- 108040–108040
- Publication date
- 19 January 2026
- Language
- EN